Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
José Francisco García Juan, La traducción latina interlineal de los LXX en la Biblia Políglota Complutense: Libro de los Proverbios. CSIC, 2023.
View through CrossRef
García Juan, José Francisco, La Traducción Latina Interlineal de los LXX en la Biblia Políglota Complutense: Libro de los Proverbios. CSIC, 2023
Title: José Francisco García Juan, La traducción latina interlineal de los LXX en la Biblia Políglota Complutense: Libro de los Proverbios. CSIC, 2023.
Description:
García Juan, José Francisco, La Traducción Latina Interlineal de los LXX en la Biblia Políglota Complutense: Libro de los Proverbios.
CSIC, 2023.
Related Results
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Abstract
The fundamental value of universal nomenclatural systems in biology is that they enable unambiguous scientific communication. However, the stability of thes...
Vipengele Vya Fasihi Vinavyojenga Taswira Ya Mwanamke Katikavitabu Teule Vya Biblia Takatifu
Vipengele Vya Fasihi Vinavyojenga Taswira Ya Mwanamke Katikavitabu Teule Vya Biblia Takatifu
Lugha ni chombo cha kipekee kinachofinyangwa kuwasilisha taswira ya masuala changamano katika jamii. Matokeo haya ya lugha ni fasihi, ambayo ni kioo cha jamii. Biblia Takatifu ni k...
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
Abstract
Background
Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of posto...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract
The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
Abstract
Background
This study aimed to determine the impact of pulmonary complications on death after surgery both before and d...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background:
Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
BACKGROUND:
ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) did not find an overall reduction in cardiovascular ...